Profile data is unavailable for this security.
About the company
CHONGQING TAIJI INDUSTRY (GROUP) CO., LTD. is a China-based company principally engaged in the production and sales of Chinese and Western medicines. The Company is also engaged in the cultivation of medicinal herbs. The Company's products mainly include capsules, syrup, oral liquid, lyophilized series, tablets, infusion series and injections. The Company mainly conducts its business in domestic and overseas markets.
- Revenue in CNY (TTM)15.62bn
- Net income in CNY822.12m
- Incorporated1993
- Employees12.59k
- LocationChongqing Taiji Industry Group Co LtdNo.18Hengshan East Road, Yubei DistrictCHONGQING 401121ChinaCHN
- Phone+86 2 389886129
- Fax+86 2 389887399
- Websitehttp://www.taiji.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jiang Zhong Pharmaceutical Co Ltd | 4.39bn | 708.29m | 16.85bn | 4.01k | 23.94 | 4.37 | -- | 3.84 | 1.12 | 1.12 | 6.94 | 6.13 | 0.7078 | 4.00 | 15.58 | 1,093,970.00 | 12.36 | 10.82 | 19.43 | 15.08 | 63.88 | 65.02 | 17.46 | 18.17 | 1.26 | -- | 0.021 | 82.88 | 13.00 | 20.12 | 18.40 | 8.54 | 11.47 | 40.99 |
| Anhui Huaheng Biotechnology Co Ltd | 2.04bn | 454.44m | 16.94bn | 1.69k | 37.34 | 8.85 | -- | 8.31 | 2.88 | 2.88 | 12.92 | 12.15 | 0.6196 | 5.59 | 8.04 | 1,205,674.00 | 13.71 | 16.74 | 21.59 | 22.41 | 38.49 | 39.21 | 22.13 | 22.34 | 0.4552 | 155.98 | 0.4552 | 25.20 | 36.63 | 35.72 | 40.32 | 42.84 | 82.09 | -- |
| KPC Pharmaceuticals Inc | 7.65bn | 432.35m | 17.06bn | 5.05k | 39.14 | 3.15 | -- | 2.23 | 0.5757 | 0.5757 | 10.20 | 7.15 | 0.8021 | 2.48 | 2.62 | 1,513,702.00 | 4.63 | 5.42 | 7.76 | 9.13 | 43.12 | 43.68 | 5.77 | 5.70 | 1.46 | 53.93 | 0.1688 | 35.75 | -6.99 | 1.64 | 16.05 | 5.79 | -21.33 | 14.87 |
| Shandong Buchang Pharmaceuticals Co Ltd | 13.63bn | -1.87bn | 17.53bn | 8.49k | -- | 1.43 | -- | 1.29 | -1.69 | -1.69 | 12.32 | 11.05 | 0.6087 | 1.12 | 9.71 | 1,605,200.00 | -8.86 | 4.93 | -12.07 | 7.05 | 69.25 | 77.42 | -14.56 | 7.18 | 0.5054 | -20.16 | 0.2163 | 109.43 | -5.15 | 1.52 | -218.65 | -- | -17.89 | 0.1039 |
| Dizal Jiangsu Pharmaceutical Co Ltd | 40.10m | -1.05bn | 18.45bn | 328.00 | -- | 16.74 | -- | 460.09 | -2.59 | -2.59 | 0.0984 | 2.65 | 0.0204 | -- | 1.52 | 122,263.40 | -53.53 | -- | -66.24 | -- | 93.97 | -- | -2,630.41 | -- | 2.02 | -- | 0.202 | -- | -100.00 | -- | -9.87 | -- | -- | -- |
| Chongqing Taiji Industry Group Co Ltd | 15.62bn | 822.12m | 19.45bn | 12.59k | 23.65 | 5.37 | -- | 1.24 | 1.48 | 1.48 | 28.05 | 6.50 | 1.07 | 3.32 | 7.83 | 1,240,976.00 | 5.82 | 0.7814 | 18.62 | 2.35 | 47.39 | 44.03 | 5.46 | 0.8498 | 0.5147 | 6.18 | 0.5658 | 25.76 | 10.58 | 7.88 | 131.99 | 63.55 | 3.86 | 24.57 |
| Tonghua Dongbao Pharmaceutical Co Ltd | 3.08bn | 1.17bn | 21.11bn | 3.20k | 18.06 | 2.93 | -- | 6.86 | 0.5863 | 0.5863 | 1.54 | 3.62 | 0.4236 | 0.9223 | 5.06 | 962,270.40 | 16.09 | 18.68 | 16.89 | 19.68 | 79.62 | 78.73 | 37.98 | 39.20 | 4.06 | -- | 0.0204 | 41.73 | 10.69 | 2.69 | -26.17 | 6.85 | -14.75 | 4.56 |
| Nanjing King-Frind Bchmcl Phrmctcl C Ltd | 4.00bn | 1.02bn | 21.40bn | 1.40k | 20.86 | 3.13 | -- | 5.35 | 0.6346 | 0.6346 | 2.48 | 4.23 | 0.3813 | 0.3692 | 4.83 | 2,867,937.00 | 9.72 | 12.93 | 14.49 | 18.96 | 49.00 | 53.87 | 25.50 | 27.46 | 1.02 | -- | 0.324 | 20.30 | 0.706 | 27.25 | 2.98 | 28.26 | 42.10 | 23.27 |
| China Resources Dubl-Crne Phrmctl Co Ltd | 10.22bn | 1.33bn | 22.04bn | 12.27k | 16.30 | 1.96 | -- | 2.16 | 1.30 | 1.30 | 9.98 | 10.83 | 0.6682 | 2.72 | 7.04 | 833,167.50 | 8.67 | 8.58 | 11.59 | 11.21 | 53.94 | 58.19 | 12.97 | 11.98 | 1.92 | -- | 0.0279 | 35.91 | 6.20 | 4.44 | 12.96 | 6.60 | 21.46 | -1.63 |
| Sinocelltech Group Ltd | 1.89bn | -396.02m | 22.16bn | 2.33k | -- | -- | -- | 11.74 | -0.8893 | -0.8893 | 4.24 | -1.35 | 0.6921 | 0.342 | 5.86 | 808,979.60 | -14.55 | -40.17 | -38.38 | -74.63 | 96.42 | 95.42 | -21.03 | -108.20 | 0.4232 | 1.06 | 1.30 | -- | 84.46 | 264.19 | 23.70 | -- | 37.54 | -- |
Data as of Apr 18 2024. Currency figures normalised to Chongqing Taiji Industry Group Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
20.84%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| ICBC Credit Suisse Asset Management Co., Ltd.as of 30 Jun 2023 | 30.65m | 5.50% |
| Zhong Ou Asset Management Co., Ltdas of 30 Sep 2023 | 18.62m | 3.34% |
| Huashang Fund Management Co., Ltd.as of 30 Jun 2023 | 13.36m | 2.40% |
| Bosera Asset Management Co., Ltd.as of 30 Jun 2023 | 13.05m | 2.34% |
| CCB Principal Asset Management Co., Ltd.as of 30 Jun 2023 | 10.75m | 1.93% |
| GF Fund Management Co., Ltd.as of 30 Sep 2023 | 8.96m | 1.61% |
| Cinda Fund Management Co. Ltd.as of 30 Jun 2023 | 5.88m | 1.06% |
| China Asset Management Co., Ltd.as of 31 Jan 2024 | 5.49m | 0.99% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2023 | 4.95m | 0.89% |
| Minsheng Royal Fund Management Co., Ltd.as of 30 Jun 2023 | 4.31m | 0.77% |
More ▼
Data from 30 Jun 2023 - 18 Apr 2024Source: FactSet Research Systems Inc.
